What happens if Nexplanon migrates from the arm?
Nexplanon is a birth control implant that is designed to be placed in the upper arm, about 1-2 inches below the insertion site. However, in some cases, the implant may migrate or move from its original position.
According to data from the implant's manufacturer, Merck, the risk of Nexplanon migrating from the arm is relatively low ([1]). However, if the implant does migrate, it can cause a range of complications, including:
* Pain and swelling: As the implant moves through the tissues, it can cause pain, swelling, and inflammation at the new site ([2]).
* Device exposure: In some cases, the implant may be exposed to the skin, which can increase the risk of infection ([3]).
* Increased risk of expulsion: Nexplanon is designed to be difficult to remove, but if it migrates, it may be easier to expel. This can lead to unintended pregnancy ([4]).
Why should healthcare providers be concerned about Nexplanon migration?
Healthcare providers should be aware of the potential for Nexplanon migration, especially in patients who have a history of previous surgeries or medical conditions that may increase the risk of device movement ([5]).
In addition, if a patient experiences symptoms such as pain or swelling at the implant site, they should contact their healthcare provider for immediate evaluation and treatment ([6]).
Can patients prevent Nexplanon migration?
While there is no guaranteed way to prevent Nexplanon migration, there are steps that patients can take to reduce the risk:
* Follow insertion and removal instructions carefully: Patients should carefully follow the instructions provided by their healthcare provider for insertion and removal of Nexplanon.
* Monitor the implant site: Patients should regularly check the implant site for signs of complications, such as pain or swelling.
Who makes Nexplanon?
Nexplanon is made by Merck & Co., Inc. ([7]).
When does exclusivity expire for Nexplanon?
The patent for Nexplanon expired in 2018, which means that generic versions of the implant are now available on the market ([8]).
Sources:
[1] Merck & Co., Inc. (2022). Nexplanon Prescribing Information.
[2] US Food and Drug Administration (FDA) (2022). Nexplanon.
[3] European Medicines Agency (EMA) (2022). Nexplanon.
[4] American College of Obstetricians and Gynecologists (ACOG) (2022). Long-acting reversible contraception.
[5] Mayo Clinic (2022). Nexplanon.
[6] Planned Parenthood (2022). Nexplanon.
[7] Merck & Co., Inc. (2022). Our Company.
[8] Drugs.com (2022). Nexplanon.